Skip to main content
DGX
NYSE Industrial Applications And Services

Quest Diagnostics Reports Strong Q1 Results, Raises Full-Year Revenue & EPS Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$201
Mkt Cap
$21.568B
52W Low
$160.02
52W High
$213.5
52W Position info
26% above low
Off High info
5.9% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

DGX sits 26% above its 52-week low of $160.02 on elevated volume (2.0× avg).

Summary

Quest Diagnostics announced robust first-quarter 2026 financial results, with significant revenue and adjusted EPS growth, leading the company to raise its full-year 2026 guidance for both revenue and earnings per share.


Key Events · Earnings and Guidance · DGX

  • Reports Strong First Quarter 2026 Results

    Quest Diagnostics reported Q1 2026 revenues of $2.90 billion, a 9.2% increase from the prior year, with adjusted diluted EPS rising 13.1% to $2.50.

  • Raises Full-Year 2026 Guidance

    The company increased its full-year 2026 net revenue guidance to a range of $11.78 billion to $11.90 billion and adjusted diluted EPS guidance to $10.63 to $10.83, reflecting confidence in continued performance.

  • Advances Strategic Initiatives

    Highlights include progress in Co-Lab Solutions, robust growth in consumer channels and Advanced Diagnostics (including Quest AD-Detect®), and the launch of an AI Companion tool for patients.


Analysis · DGX · Industrial Applications And Services

This 8-K filing confirms strong operational performance for Quest Diagnostics, with Q1 revenues up 9.2% and adjusted diluted EPS increasing by 13.1% year-over-year. The company's decision to raise its full-year 2026 revenue and EPS guidance signals management's confidence in continued growth and execution of its strategic initiatives. This positive financial update, following a news alert earlier today, provides comprehensive details that reinforce a positive outlook for the company.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DGX was trading at $201.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $21.6B. The 52-week trading range was $160.02 to $213.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DGX - Latest Insights

DGX
Oct 23, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $241.89
Real-time Price: $259.60 info
Change: +$17.71 (+7%) info
Market Cap: $28.551B info
DGX
Oct 23, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $238.42
Real-time Price: $259.60 info
Change: +$21.18 (+9%) info
Market Cap: $28.551B info
DGX
Oct 22, 2026, 11:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $236.45
Real-time Price: $259.60 info
Change: +$23.15 (+10%) info
Market Cap: $28.551B info
DGX
Oct 22, 2026, 6:53 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $236.57
Real-time Price: $259.60 info
Change: +$23.03 (+10%) info
Market Cap: $28.551B info
DGX
Oct 22, 2026, 6:49 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $236.57
Real-time Price: $259.60 info
Change: +$23.03 (+10%) info
Market Cap: $28.551B info